Mustang Bio secures CAR-T production site
biopharmadive | November 02, 2017
Up-and-coming CAR-T developer Mustang Bio Inc. has locked down a production facility to better support clinical development of its cell therapy pipeline, announcing this week it will lease a site in the UMass Medicine Science Park in Worcester, Massachusetts.